R. Katherine Alpaugh

Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.

M. Shahin, Wei Hu, J. Fiorica, 2012, Gynecologic oncology.

Normal Variants and Pitfalls Encountered in PET Assessment of Gynecologic Malignancies.

R. Alpaugh, J. Yu, M. Doss, 2018, PET clinics.

Biodistribution and Radiation Dosimetry of the Carbonic Anhydrase IX Imaging Agent [18 F]VM4-037 Determined from PET/CT Scans in Healthy Volunteers

Zhihong Zhu, David Y. T. Chen, R. Alpaugh, 2014, Molecular Imaging and Biology.

A phase II evaluation of aflibercept in the treatment of recurrent or persistent endometrial cancer: a Gynecologic Oncology Group study.

A. Godwin, A. Sood, C. Drescher, 2012, Gynecologic oncology.